PMAQX
Price
$46.83
Change
+$0.02 (+0.04%)
Updated
Oct 8 closing price
Net Assets
32.87B
PSKCX
Price
$44.96
Change
+$0.40 (+0.90%)
Updated
Oct 8 closing price
Net Assets
923.46M
Interact to see
Advertisement

PMAQX vs PSKCX

Header iconPMAQX vs PSKCX Comparison
Open Charts PMAQX vs PSKCXBanner chart's image
Principal MidCap R6
Price$46.83
Change+$0.02 (+0.04%)
VolumeN/A
Net Assets32.87B
Virtus KAR Mid-Cap Growth C
Price$44.96
Change+$0.40 (+0.90%)
VolumeN/A
Net Assets923.46M
PMAQX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
PMAQX vs. PSKCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Hold and PSKCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 32.9B vs. PSKCX (923M). PMAQX pays higher dividends than PSKCX: PMAQX (0.19) vs PSKCX (0.00). PMAQX was incepted earlier than PSKCX: PMAQX (9 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than PMAQX (0.59). PSKCX is a more actively managed with annual turnover of: 13.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than PSKCX: PMAQX (0) vs PSKCX (2500). PMAQX annual gain was more profitable for investors over the last year : 2.93 vs. PSKCX (0.38). PMAQX return over 5 years is better than : 41.18 vs. PSKCX (-7.88).
PMAQXPSKCXPMAQX / PSKCX
Total Expense Ratio0.592.0429%
Annual Report Gross Expense Ratio0.592.0429%
Fund Existence9 years25 years-
Gain YTD4.8850.564866%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets32.9B923M3,564%
Annual Yield % from dividends0.190.00-
Returns for 1 year2.930.38764%
Returns for 3 years55.1332.30171%
Returns for 5 years41.18-7.88-523%
Returns for 10 yearsN/A152.04-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FATE1.510.12
+8.63%
Fate Therapeutics
ALUR2.170.10
+4.83%
Allurion Technologies
PHAT11.050.21
+1.94%
Phathom Pharmaceuticals
ERIC8.540.11
+1.30%
Ericsson
EEFT86.53-0.39
-0.45%
Euronet Worldwide